Bone loss is most commonly associated with antiretroviral therapy, which is needed by HIV patients. Now, a new study found that osteoporosis drug Zoledronic Acid may help prevent bone loss even while under treatment.
Bone loss is most commonly associated with antiretroviral therapy, which is needed by HIV patients. Now, a new study found that osteoporosis drug Zoledronic Acid may help prevent bone loss even while under treatment.